|
[1]
|
Son, D.H., Ha, H.S., Park, H.M., et al. (2022) New Markers in Metabolic Syndrome. Advances in Clinical Chemistry, 110, 37-71.
|
|
[2]
|
Buono, G., Crispo, A., Giuliano, M., De Angelis, C., Schettini, F., Forestieri, V., et al. (2020) Metabolic Syndrome and Early Stage Breast Cancer Outcome: Results from a Prospective Observational Study. Breast Cancer Research and Treatment, 182, 401-409. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Maiti, B., Kundranda, M.N., Spiro, T.P. and Daw, H.A. (2009) The Association of Metabolic Syndrome with Triple-Negative Breast Cancer. Breast Cancer Research and Treatment, 121, 479-483. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kabat, G.C., Kim, M., Chlebowski, R.T., Khandekar, J., Ko, M.G., McTiernan, A., et al. (2009) A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 18, 2046-2053. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Uzunlulu, M., Telci Caklili, O. and Oguz, A. (2016) Association between Metabolic Syndrome and Cancer. Annals of Nutrition and Metabolism, 68, 173-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Gershuni, V.M., Ahima, R.S. and Tchou, J. (2016) Obesity and Breast Cancer: A Complex Relationship. Current Surgery Reports, 4, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Motoki, A.H., Buttros, D.A.B., Gaspar, A.L., Almeida-Filho, B.S., Carvalho-Pessoa, E., Vespoli, H.D.L., et al. (2022) Association between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women. Clinical Breast Cancer, 22, e253-e261. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Buttros Dde, A., Nahas, E.A., Vespoli Hde, L., Uemura, G., de Almeida Bda, R. and Nahas-Neto, J. (2013) Risk of Metabolic Syndrome in Postmenopausal Breast Cancer Survivors. Menopause, 20, 448-454. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Carr, M.C. (2003) The Emergence of the Metabolic Syndrome with Menopause. The Journal of Clinical Endocrinology & Metabolism, 88, 2404-2411. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Park, Y., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R. and Heymsfield, S.B. (2003) The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine, 163, 427-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lobo, R.A. (2008) Metabolic Syndrome after Menopause and the Role of Hormones. Maturitas, 60, 10-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Healy, L.A., Ryan, A.M., Carroll, P., Ennis, D., Crowley, V., Boyle, T., et al. (2010) Metabolic Syndrome, Central Obesity and Insulin Resistance Are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer. Clinical Oncology, 22, 281-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Xue, F. and Michels, K.B. (2007) Diabetes, Metabolic Syndrome, and Breast Cancer: A Review of the Current Evidence. The American Journal of Clinical Nutrition, 86, 823S-835S. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Vona-Davis, L., Howard-McNatt, M. and Rose, D.P. (2007) Adiposity, Type 2 Diabetes and the Metabolic Syndrome in Breast Cancer. Obesity Reviews, 8, 395-408. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hallajzadeh, J., Khoramdad, M., Izadi, N., Karamzad, N., Almasi-Hashiani, A., Ayubi, E., et al. (2018) Metabolic Syndrome and Its Components in Premenopausal and Postmenopausal Women: A Comprehensive Systematic Review and Meta-Analysis on Observational Studies. Menopause, 25, 1155-1164. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Cao, Z., Zheng, X., Yang, H., Li, S., Xu, F., Yang, X., et al. (2020) Association of Obesity Status and Metabolic Syndrome with Site-Specific Cancers: A Population-Based Cohort Study. British Journal of Cancer, 123, 1336-1344. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhao, P., Xia, N., Zhang, H. and Deng, T. (2020) The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis. Obesity Facts, 13, 384-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mendonça, F.M., de Sousa, F.R., Barbosa, A.L., Martins, S.C., Araújo, R.L., Soares, R., et al. (2015) Metabolic Syndrome and Risk of Cancer: Which Link? Metabolism, 64, 182-189. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Fernandes, J.V., Cobucci, R.N.O., Jatobá, C.A.N., de Medeiros Fernandes, T.A.A., de Azevedo, J.W.V. and de Araújo, J.M.G. (2015) The Role of the Mediators of Inflammation in Cancer Development. Pathology & Oncology Research, 21, 527-534. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Crespi, E., Bottai, G. and Santarpia, L. (2016) Role of Inflammation in Obesity-Related Breast Cancer. Current Opinion in Pharmacology, 31, 114-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Guo, M., Liu, T., Li, P., Wang, T., Zeng, C., Yang, M., et al. (2019) Association between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies. Frontiers in Oncology, 9, Article 1290. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Goldberg, J.E. and Schwertfeger, K.L. (2010) Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics. Current Drug Targets, 11, 1133-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cullen, K.J., Yee, D., Sly, W.S., et al. (1990) Insulin-Like Growth Factor Receptor Expression and Function in Human Breast Cancer. Cancer Research, 50, 48-53.
|
|
[24]
|
Belfiore, A., Frittitta, L., Costantino, A., Frasca, F., Pandini, G., Sciacca, L., et al. (1996) Insulin Receptors in Breast Cancer. Annals of the New York Academy of Sciences, 784, 173-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Papa, V., Pezzino, V., Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., et al. (1990) Elevated Insulin Receptor Content in Human Breast Cancer. Journal of Clinical Investigation, 86, 1503-1510. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Mathieu, M.C., Clark, G.M., Allred, D.C., et al. (1997) Insulin Receptor Expression and Clinical Outcome in Node-Negative Breast Cancer. Proceedings of the Association of American Physicians, 109, 565-571.
|
|
[27]
|
Hauner, D. and Hauner, H. (2014) Metabolic Syndrome and Breast Cancer: Is There a Link? Breast Care, 9, 277-281. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Mauro, L., Naimo, G.D., Ricchio, E., Panno, M.L. and Andò, S. (2015) Cross-talk between Adiponectin and IGF-IR in Breast Cancer. Frontiers in Oncology, 5, Article 157. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Xia, B., Hou, L., Kang, H., Chang, W., Liu, Y., Zhang, Y., et al. (2020) NR2F2 Plays a Major Role in Insulin-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells. BMC Cancer, 20, Article No. 626. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wairagu, P.M., Phan, A.N., Kim, M., Han, J., Kim, H., Choi, J., et al. (2015) Insulin Priming Effect on Estradiol-Induced Breast Cancer Metabolism and Growth. Cancer Biology & Therapy, 16, 484-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Vara, J.Á.F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C. and González-Barón, M. (2004) PI3K/Akt Signalling Pathway and Cancer. Cancer Treatment Reviews, 30, 193-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Bastarrachea, R.A., López-Alvarenga, J.C., Bolado-García, V.E., et al. (2007) [Macrophages, Inflammation, Adipose Tissue, Obesity and Insulin Resistance]. Gaceta Medica de Mexico, 143, 505-512.
|
|
[33]
|
Buono, G., Crispo, A., Giuliano, M., De Angelis, C., Schettini, F., Forestieri, V., et al. (2020) Metabolic Syndrome and Early Stage Breast Cancer Outcome: Results from a Prospective Observational Study. Breast Cancer Research and Treatment, 182, 401-409. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Hagemann, T., Wilson, J., Kulbe, H., Li, N.F., Leinster, D.A., Charles, K., et al. (2005) Macrophages Induce Invasiveness of Epithelial Cancer Cells via NF-κB and JNK. The Journal of Immunology, 175, 1197-1205. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Tomita, Y., Yang, X., Ishida, Y., Nemoto-Sasaki, Y., Kondo, T., Oda, M., et al. (2004) Spontaneous Regression of Lung Metastasis in the Absence of Tumor Necrosis Factor Receptor P55. International Journal of Cancer, 112, 927-933. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Balkwill, F. (2009) Tumour Necrosis Factor and Cancer. Nature Reviews Cancer, 9, 361-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a Key Event in Cancer Development. Molecular Cancer Research, 4, 221-233. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
van Kruijsdijk, R.C.M., van der Wall, E. and Visseren, F.L.J. (2009) Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Cancer Epidemiology, Biomarkers & Prevention, 18, 2569-2578. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Trinchieri, G. (2012) Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts. Annual Review of Immunology, 30, 677-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Uzunlulu, M., Telci Caklili, O. and Oguz, A. (2016) Association between Metabolic Syndrome and Cancer. Annals of Nutrition and Metabolism, 68, 173-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Zorena, K., Jachimowicz-Duda, O., Ślęzak, D., Robakowska, M. and Mrugacz, M. (2020) Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. International Journal of Molecular Sciences, 21, Article 3570. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Forte, V., Pandey, A., Abdelmessih, R., Forte, G., Whaley-Connell, A., Sowers, J.R., et al. (2012) Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Medicine, 2, 143-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Shen, W., Punyanitya, M., Silva, A.M., Chen, J., Gallagher, D., Sardinha, L.B., et al. (2009) Sexual Dimorphism of Adipose Tissue Distribution across the Lifespan: A Cross-Sectional Whole-Body Magnetic Resonance Imaging Study. Nutrition & Metabolism, 6, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
La Vecchia, C., Negri, E., Franceschi, S., Talamini, R., Bruzzi, P., Palli, D., et al. (1997) Body Mass Index and Post-Menopausal Breast Cancer: An Age-Specific Analysis. British Journal of Cancer, 75, 441-444. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Key, T.J., Appleby, P.N., Reeves, G.K., et al. (2003) Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women. JNCI Journal of the National Cancer Institute, 95, 1218-1226. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Lorincz, A.M. and Sukumar, S. (2006) Molecular Links between Obesity and Breast Cancer. Endocrine-Related Cancer, 13, 279-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Dibaba, D.T., Ogunsina, K., Braithwaite, D. and Akinyemiju, T. (2018) Metabolic Syndrome and Risk of Breast Cancer Mortality by Menopause, Obesity, and Subtype. Breast Cancer Research and Treatment, 174, 209-218. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Lawlor, D.A., Smith, G.D. and Ebrahim, S. (2004) Hyperinsulinaemia and Increased Risk of Breast Cancer: Findings from the British Women’s Heart and Health Study. Cancer Causes & Control, 15, 267-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Berrino, F., Villarini, A., Traina, A., Bonanni, B., Panico, S., Mano, M.P., et al. (2014) Metabolic Syndrome and Breast Cancer Prognosis. Breast Cancer Research and Treatment, 147, 159-165. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Giacosa, A., Barale, R., Bavaresco, L., Gatenby, P., Gerbi, V., Janssens, J., et al. (2013) Cancer Prevention in Europe: The Mediterranean Diet as a Protective Choice. European Journal of Cancer Prevention, 22, 90-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wang, M., Cheng, N., Zheng, S., Wang, D., Hu, X., Ren, X., et al. (2015) Metabolic Syndrome and the Risk of Breast Cancer among Postmenopausal Women in North-West China. Climacteric, 18, 852-858. [Google Scholar] [CrossRef] [PubMed]
|